Manufacturer record

Ultra Drugs Pvt. Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

13 batches manufactured by Ultra Drugs Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between August 2021 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

13 records linked to Ultra Drugs Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
13Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Aug 2021 to Feb 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

13
NSQ batches since 2021
10
Products affected
Dissolution
Most common failure
Feb 2026
Latest alert

Flagged batches per year

2021 · 12022 · 12023 · 12024 · 42025 · 52026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Levocetirizine Hydrochloride and Montelukast Sodium Tablets IP UGT-25293LMfg 2025-03 · Exp 2027-02 The sample does not conform to I.P.w.r.t. the test for DissolutionDissolution SDTL, AssamState lab Feb 2026
Levocetirizine Hydrochloride & Montelukast Sodium Tablets IP (Alticet-M) UGT-24842BMfg 2024-08 · Exp 2026-07 Failed Description (Spots)Description DTL, PuducherryState lab Dec 2025
Baptar NM Tablet (Pregabalin Methylcobalamin & Nortriptyline Tablets) UGT-25134EMfg 2025-01 · Exp 2026-12 AssayAssay DTL Baddi H.PState lab Oct 2025
CEFPODOXIME PROXETIL DISPERSIBLE Tablets UCT-25327HMfg 2025-08 · Exp 2027-07 Uniformity of Dispersion.Uniformity of weight/content SDTL, PunjabState lab Sep 2025
Amoxycillin & Potassium Clavulanate for Oral Suspension, UPS-245CMfg 2024-01 · Exp 2025-06 The drug product Amoxcycillin and potassium Clavulanate for Oral suspension is official in the current edition of IP 2022. But the designation in conjiction with the product title Amoxycillin and Potassium Clavulanate for Oral suspension IP is not mentioned on the product LabelLabelling State Lab, Drugs Control Laboratory, TelanganaState lab May 2025
Methylcobalamin, Thiamine HCl, Pyridoxine HCl, D- Panthenol and Nicotinamide Injection (Nuropat) UGA-24436EMfg 2024-08 · Exp 2026-01 Particulate Matter and Assay of MethylcobalaminAssay CDL, KolkataCDSCO lab Mar 2025
Pantoprazole Gastro-resistant and Domperidone Prolonged- release Capsules IP (Unipraz - DSR) UC-23001CMfg 2023-07 · Exp 2025-06 "Dissolution of Domperidone"Dissolution CDTL MumbaiCDSCO lab Dec 2024
Rabeprazole Sodium (Enteric Coated) And Domperidone (Sustained Release) Capsules (ZABIL- DSR) UD2C- 23469EMfg 2023-06 · Exp 2025-05 Dissolution of Rabeprazole & Domperidone, Assay of DomperidoneAssay CDL KolkataCDSCO lab Oct 2024
Itraconazole Capsules BP 100 mg UC-23240AMfg 2023-10 · Exp 2025-09 DissolutionDissolution CDL KolkataCDSCO lab Jul 2024
SOFTOM-D Omeprazole and Domperidone Capsules IP UD2C- 23252BMfg 2023-04 · Exp 2025-03 THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR OMEPRAZOLE AND DOMPERIDONE CAPSULES FOR THE DISSOLUTION TEST (OMEPRAZOLE).Dissolution State Lab MaharashtraState lab Jun 2024
Cefpodoxime Proxetil for Oral Suspension IP UCST- 2310Mfg 2023-03 · Exp 2025-02 pHpH RDTL ChandigarhCDSCO lab Aug 2023
Cefpodoxime Proxetil Dispersible Tablets 200 mg UCT-22159Mfg 2022-05 · Exp 2024-04 Uniformity of DispersionUniformity of weight/content CDL KolkataCDSCO lab Nov 2022
Doulcet-M Tablets, (Levocetrizine Dihydrochloride & Montelukast Sodium) UDT-20163CMfg 2020-02 · Exp 2022-01 Dissolution of MontelukastDissolution RDTL GuwahatiState lab Aug 2021

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.